Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
HonorHealth Research Institute
HonorHealth Research Institute
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
St. Jude Children's Research Hospital
University of Michigan Rogel Cancer Center
University of Nebraska
Vanderbilt University Medical Center
Sahlgrenska University Hospital
Assistance Publique Hopitaux De Marseille
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Abramson Cancer Center at Penn Medicine
Instituto do Cancer do Estado de São Paulo
Odense University Hospital
Western Sydney Local Health District
Johns Hopkins University
University Hospital, Toulouse
Hospices Civils de Lyon
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Shanghai Zhongshan Hospital
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Yonsei University
Universitätsklinikum Hamburg-Eppendorf
Royal Marsden NHS Foundation Trust
University of Copenhagen
University Medical Center Groningen
Hôpital Edouard Herriot
Peking Union Medical College Hospital
M.D. Anderson Cancer Center
Universitaire Ziekenhuizen KU Leuven
Yonsei University
M.D. Anderson Cancer Center
Charite University, Berlin, Germany
Charite University, Berlin, Germany
University of Puerto Rico
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Changhai Hospital
Yonsei University
Copenhagen University Hospital, Hvidovre
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Boston Medical Center
University of Utah
University of Sao Paulo
King Chulalongkorn Memorial Hospital
Radboud University Medical Center
Johns Hopkins University
Nantes University Hospital
Mansoura University
Assistance Publique - Hôpitaux de Paris